PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 34 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,580 | +17.2% | 50,000 | 0.0% | 0.00% | – |
Q2 2023 | $3,055 | +52.4% | 50,000 | 0.0% | 0.00% | – |
Q1 2023 | $2,005 | -7.0% | 50,000 | 0.0% | 0.00% | – |
Q4 2022 | $2,155 | -46.1% | 50,000 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -20.0% | 50,000 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -54.5% | 50,000 | 0.0% | 0.00% | – |
Q1 2022 | $11,000 | -47.6% | 50,000 | 0.0% | 0.00% | – |
Q4 2021 | $21,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atalaya Capital Management LP | 225,000 | $15,750 | 0.02% |
Q Global Advisors, LLC | 170,785 | $12 | 0.01% |
MMCAP International Inc. SPC | 375,000 | $26,850 | 0.01% |
PERISCOPE CAPITAL INC. | 957,098 | $68,528 | 0.01% |
CVI Holdings, LLC | 44,106 | $3,158 | 0.01% |
Silver Rock Financial LP | 12,224 | $875 | 0.01% |
Castle Creek Arbitrage, LLC | 200,000 | $14,320 | 0.00% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 714,827 | $51,182 | 0.00% |
Segantii Capital Management Ltd | 5,000 | $54,300 | 0.00% |
GRITSTONE ASSET MANAGEMENT LLC | 17,014 | $1,218 | 0.00% |